Alzheimer’s disease neuropathological change (ADNC) is characterised by the presence of amyloid and phosphorylated tau (p-tau) in the brain, which when associated with clinical dementia is Alzheimer’s disease (AD). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.